welcome
CNBC

CNBC

Health

Health

Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal

CNBC
Summary
Nutrition label

85% Informative

Merck will pay Hansoh $112 million upfront for rights to the drug, with the potential for an additional $1.9 billion in milestone payments and royalties on sales.

The oral drug has not yet entered human trials, and Merck did not specify which diseases it plans to test the drug on first .

Several other drugmakers, including Pfizer and Roche , are racing to develop more convenient obesity pills.

VR Score

90

Informative language

93

Neutral language

65

Article tone

formal

Language

English

Language complexity

51

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

Source diversity

1

Affiliate links

no affiliate links